Contradictory iPledge Requirements Hinder Physician Practice and Patient Care-Reply

JAMA Dermatol. 2020 Feb 1;156(2):222-223. doi: 10.1001/jamadermatol.2019.3651.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Dermatologic Agents* / therapeutic use
  • Female
  • Humans
  • Isotretinoin
  • Patient Care
  • Pregnancy
  • United States
  • United States Food and Drug Administration

Substances

  • Dermatologic Agents
  • Isotretinoin